Cited by 548Ubiquitin and proteasome pathwaysCancer-related Molecular PathwaysPI3K/AKT/mTOR signaling in cancer

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network

Open access

Song, Min Sup, Salmena, Leonardo, Carracedo, Arkaitz, Egia, Ainara, Lo-Coco, Francesco, Teruya-Feldstein, Julie, Pandolfi, Pier Paolo·2008·Nature

DOI 10.1038/nature07290PMC PMC3398484

Open this paper in CoChat — free account

Abstract

Nuclear exclusion of the PTEN (phosphatase and tensin homologue deleted in chromosome 10) tumour suppressor has been associated with cancer progression. However, the mechanisms leading to this aberrant PTEN localization in human cancers are currently unknown. We have previously reported that ubiquitinylation of PTEN at specific lysine residues regulates its nuclear-cytoplasmic partitioning. Here we show that functional promyelocytic leukaemia protein (PML) nuclear bodies co-ordinate PTEN localization by opposing the action of a previously unknown PTEN-deubiquitinylating enzyme, herpesvirus-associated ubiquitin-specific protease (HAUSP, also known as USP7), and that the integrity of this molecular framework is required for PTEN to be able to enter the nucleus. We find that PTEN is aberrantly localized in acute promyelocytic leukaemia, in which PML function is disrupted by the PML-RARalpha fusion oncoprotein. Remarkably, treatment with drugs that trigger PML-RARalpha degradation, such as all-trans retinoic acid or arsenic trioxide, restore nuclear PTEN. We demonstrate that PML opposes the activity of HAUSP towards PTEN through a mechanism involving the adaptor protein DAXX (death domain-associated protein). In support of this paradigm, we show that HAUSP is overexpressed in human prostate cancer and is associated with PTEN nuclear exclusion. Thus, our results delineate a previously unknown PML-DAXX-HAUSP molecular network controlling PTEN deubiquitinylation and trafficking, which is perturbed by oncogenic cues in human cancer, in turn defining a new deubiquitinylation-dependent model for PTEN subcellular compartmentalization.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature07290

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform
Rhodes, D. R., Yu, J., Sundaram, S. K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T. R., Pander, A., & Chinnaiyan, A. M. (2004) · Neoplasia · doi:10.1016/s1476-5586(04)80047-2 · Cited by 3,719
The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate
Maehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81780-8 · Cited by 2,551
Tenets of PTEN Tumor Suppression
Salmena, L., Carracedo, A., & Pandolfi, P. P. (2008) · Cell · doi:10.1016/j.cell.2008.04.013 · Cited by 1,050
Self-citation
Essential role for nuclear PTEN in maintaining chromosomal integrity
Shen, W. H., Balajee, A. S., Wang, J., Wu, H., Eng, C., Pandolfi, P. P., & Yin, Y. (2007) · Cell · doi:10.1016/j.cell.2006.11.042 · Cited by 979
Self-citation
Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies
Bernardi, R., & Pandolfi, P. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2277 · Cited by 876
Self-citation
RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation
Tatham, M. H., Geoffroy, M., Shen, L., Plechanovová, A., Hattersley, N., Jaffray, E., Palvimo, J. J., & Hay, R. T. (2008) · Nature Cell Biology · doi:10.1038/ncb1716 · Cited by 837
Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2
Li, M., Brooks, C. L., Wu-Baer, F., Chen, D., Baer, R., & Gu, W. (2003) · Science · doi:10.1126/science.1091362 · Cited by 804
PTEN: One Gene, Many Syndromes
Eng, C. (2003) · Human Mutation · doi:10.1002/humu.10257 · Cited by 787
Ubiquitination regulates PTEN nuclear import and tumor suppression
Trotman, L. C., Wang, X., Alimonti, A., Chen, Z., Teruya-Feldstein, J., Yang, H., Pavletich, N. P., Carver, B. S., Cordon-Cardo, C., Erdjument-Bromage, H., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.040 · Cited by 748
Self-citation

Flagged first, then by citations

Show all 34 references

Sorted by citations

Items 301–400 of 546

Rab5 and Ndfip1 Are Involved in Pten Ubiquitination and Nuclear Trafficking
Li, Y., Low, L., Putz, U., Goh, C., Tan, S., & Howitt, J. A. (2014) · Traffic · doi:10.1111/tra.12175 · Cited by 24
Ubiquitin-Specific Proteases as Druggable Targets.
Davis, M. I., & Simeonov, A. M. (2015) · PubMed · Cited by 24
Targeting POH1 inhibits prostate cancer cell growth and enhances the suppressive efficacy of androgen deprivation and docetaxel
Yu, W., Li, J., Wang, Q., Wang, B., Zhang, L., Liu, Y., Tang, M., Xu, G., Yang, Z., Wang, X., et al. (2019) · The Prostate · doi:10.1002/pros.23838 · Cited by 24
The Role of Deubiquitinating Enzymes in Hematopoiesis and Hematological Malignancies
Sarodaya, N., Karapurkar, J. K., Kim, K.-S., Hong, S.-H., & Ramakrishna, S. (2020) · Cancers · doi:10.3390/cancers12051103 · Cited by 24
Regulation of epidermal differentiation through KDF1‐mediated deubiquitination of IKKα
Li, Y., Tang, L., Yue, J., Gou, X., Lin, A., Weatherbee, S. D., & Wu, X. (2020) · EMBO Reports · doi:10.15252/embr.201948566 · Cited by 24
The Ubiquitin-Proteasome System (UPS) as a Cancer Drug Target: Emerging Mechanisms and Therapeutics
Mata-Cantero, L., Lobato-Gil, S., Aillet, F., Lang, V., & Rodríguez, M. S. (2014) · Springer eBooks · doi:10.1007/978-94-017-9421-3_11 · Cited by 25
USP7 substrates identified by proteomics analysis reveal the specificity of USP7Preprint
Nie, L., Wang, C., Liu, X., Teng, H., Li, S., Huang, M., Feng, X., Pei, G., Hang, Q., Zhao, Z., et al. (2022) · Genes & Development · doi:10.1101/gad.349848.122 · Cited by 24
Inhibiting Multiple Deubiquitinases to Reduce Androgen Receptor Expression in Prostate Cancer Cells
Pozas, A. D. L., Reiner, T., Cesare, V. D., Trost, M., & Perez‐Stable, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-31567-3 · Cited by 23
Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells
Staniek, J., Kalina, T., Andrieux, G., Boerries, M., Janowska, I., Fuentes, M., Díez, P., Bakardjieva, M., Stančíková, J., Raabe, J., et al. (2024) · Science Immunology · doi:10.1126/sciimmunol.adj5948 · Cited by 23
Regulation of the tumor suppressor PML by sequential post-translational modifications
Schmitz, M. L., & Grishina, I. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00204 · Cited by 23
Ubiquitin-Specific Protease 7 (USP7) as a Promising Therapeutic Target for Drug Discovery: From Mechanisms to Therapies
Song, Y., Ren, X., Xiong, J., Wang, W., Zhao, Q., Chang, J., & Yu, B. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00102 · Cited by 22
USP13 regulates HMGB1 stability and secretion through its deubiquitinase activity
Shin, J., Kim, Y. H., Lee, B., Chang, J. H., Choi, H. Y., Lee, H., Song, K. C., Kwak, M. S., Choi, J. E., & Shin, J. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00596-0 · Cited by 22
Deubiquitylation Machinery Is Required for Embryonic Polarity in Caenorhabditis elegans
McCloskey, R. J., & Kemphues, K. J. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003092 · Cited by 22
Targeting of leukemia-initiating cells in acute promyelocytic leukemia.
Testa, U., & Lo‐Coco, F. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2306-9759.2015.04.03 · Cited by 22
Self-citation
Signaling Activation and Modulation in Extrafollicular B Cell Responses
Staniek, J., & Rizzi, M. (2025) · Immunological Reviews · doi:10.1111/imr.70004 · Cited by 22
Sorting the nuclear proteome
Bauer, D. C., Willadsen, K., Buske, F. A., Cao, K. L., Bailey, T. L., Dellaire, G., & Mikael Bodén, A. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr217 · Cited by 21
Chapter Seven - When Phosphorylation Encounters Ubiquitination: A Balanced Perspective on IGF-1R Signaling
Girnita, L., Takahashi, S., Crudden, C., Fukushima, T., Worrall, C., Furuta, H., Yoshihara, H., Hakuno, F., & Girnita, A. (2016) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.04.001 · Cited by 21
The emerging role of deubiquitylating enzymes as therapeutic targets in cancer metabolism
Tu, R., Ma, J., Zhang, P., Kang, Y., Xiong, X., Zhu, J., Li, M., & Zhang, C. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02524-y · Cited by 24
Ubiquitin specific peptidases and prostate cancer
Guo, Y., Cui, S., Chen, Y., Guo, S., & Chen, D. (2023) · PeerJ · doi:10.7717/peerj.14799 · Cited by 20
The SUMOylation and ubiquitination crosstalk in cancer
Li, K., Xia, Y., He, J., Wang, J., Li, J., Ye, M., & Jin, X. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05310-z · Cited by 20
The ubiquitin-proteasome system in the regulation of tumor dormancy and recurrence
Alhasan, B. A., Morozov, A. V., Guzhova, I. V., & Margulis, B. A. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189119 · Cited by 20
USP7 stabilizes EZH2 and enhances cancer malignant progression.
Zheng, N., Chu, M., Lin, M., He, Y., & Wang, Z. P. (2020) · PubMed · Cited by 20
Correction: Stem Cell Factor SALL4 Represses the Transcriptions of PTEN and SALL1 through an Epigenetic Repressor Complex
Lu, J., Jeong, H., Kong, N. R., Yang, Y., Carroll, J., Luo, H. R., Silberstein, L. E., YupoMa, & Chai, L. (2009) · PLoS ONE · doi:10.1371/annotation/e0bd3a57-1ce4-4eaf-83de-034d39cac787 · Cited by 20
PML: An emerging tumor suppressor and a target with therapeutic potential.
Reineke, E. L., & Kao, H. (2009) · PubMed · Cited by 19
TRIMming Down Hormone-Driven Cancers: The Biological Impact of TRIM Proteins on Tumor Development, Progression and Prognostication
Pauletto, E., Eickhoff, N., Padrão, N., Blattner, C., & Zwart, W. T. (2021) · Cells · doi:10.3390/cells10061517 · Cited by 19
The PTEN and Myotubularin Phosphoinositide 3-Phosphatases: Linking Lipid Signalling to Human Disease
Davies, E. M., Sheffield, D. A., Tibarewal, P., Fedele, C. G., Mitchell, C. A., & Leslie, N. R. (2012) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-3012-0_8 · Cited by 19
Controlling PTEN (Phosphatase and Tensin Homolog) Stability
Gupta, A. K., & Leslie, N. R. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.727750 · Cited by 19
Targeting the signalling pathways regulated by deubiquitinases for prostate cancer therapeutics
Islam, M. T., Zhou, X., Chen, F., Khan, M. A., Fu, J., & Chen, H. (2019) · Cell Biochemistry and Function · doi:10.1002/cbf.3401 · Cited by 18
Inhibition of ubiquitin specific protease 17 restrains prostate cancer proliferation by regulation of epithelial-to-mesenchymal transition (EMT) via ROS production
Baohai, X., Shi, F., & Yongqi, F. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108946 · Cited by 18
Role of the DUB enzyme USP7 in dendritic arborization, neuronal migration, and autistic-like behaviors in mice
Qiao, H., Tian, Y., Huo, Y., & Man, H. (2022) · iScience · doi:10.1016/j.isci.2022.104595 · Cited by 19
Ubiquitin-specific protease 7 prevents recurrent spontaneous abortion by targeting enhancer of zeste homolog 2 to regulate trophoblast proliferation, apoptosis, migration, and invasion through the Wnt/β-catenin pathway
Zhou, M., Yue, G., Wu, S., Chen, J., Ding, J., Wang, Y., & Yang, J. (2023) · Biology of Reproduction · doi:10.1093/biolre/ioad053 · Cited by 20
The RNF214-TEAD-YAP signaling axis promotes hepatocellular carcinoma progression via TEAD ubiquitylation
Lin, M., Zheng, X., Yan, J., Huang, F., Chen, Y., Ding, R., Wan, J., Zhang, L., Wang, C., Pan, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49045-y · Cited by 20
Lung neuroendocrine tumors: correlation of ubiquitinylation and sumoylation with nucleo-cytosolic partitioning of PTEN
Collaud, S., Tischler, V., Atanassoff, A., Wiedl, T., Komminoth, P., Oehlschlegel, C., Weder, W., & Soltermann, A. (2015) · BMC Cancer · doi:10.1186/s12885-015-1084-5 · Cited by 18
USP7/HAUSP: A SUMO deubiquitinase at the heart of DNA replication
Smits, V. A. J., & Freire, R. (2016) · BioEssays · doi:10.1002/bies.201600096 · Cited by 20
High dose isoleucine stabilizes nuclear PTEN to suppress the proliferation of lung cancer
Wang, H., Chen, S., Kang, W., Ding, B., Cui, S., Zhou, L., Zhang, N., Luo, H., Wang, M., Zhang, F., et al. (2023) · Discover Oncology · doi:10.1007/s12672-023-00634-1 · Cited by 18
The role of PML in hematopoietic and leukemic stem cell maintenance
Nakahara, F., Weiss, C. N., & Ito, K. (2014) · International Journal of Hematology · doi:10.1007/s12185-014-1518-x · Cited by 18
Epigallocatechin-3-gallate promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells via PTEN
Yao, S., Zhong, L., Chen, M., Zhao, Y., Li, L., Liu, L., Xu, T., Xiao, C., Gan, L., Shan, Z., et al. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4086 · Cited by 18
Divergence of P53, PTEN, PI3K, Akt and mTOR expression in tonsillar cancer
Chun, S. H., Jung, C. K., Won, H. S., Kang, J., Kim, Y., & Kim, M. (2014) · Head & Neck · doi:10.1002/hed.23643 · Cited by 18
Therapeutic targeting of ubiquitin-specific protease 7 (USP7): Mechanistic insights, dysregulation, and advances in drug discovery
El-Hamaky, A. A., El‐Hamamsy, M. H., El-Moselhy, T. F., Sharafeldin, N., & Tawfik, H. O. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117872 · Cited by 17
Nicotinate-curcumin inhibits AngII-induced vascular smooth muscle cell phenotype switching by upregulating Daxx expression
Sun, S., Cao, Y., Huo, Y., Qiu, F., Quan, W., He, C.-P., Chen, Y., Liao, D., & Tuo, Q. (2021) · Cell Adhesion & Migration · doi:10.1080/19336918.2021.1909899 · Cited by 17
Divergent Modulation of Proteostasis in Prostate Cancer
Ballar, P., Tepedelen, B. E., Gözen, O., & Erzurumlu, Y. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38266-7_5 · Cited by 17
Recent advances in the pharmacological targeting of ubiquitin-regulating enzymes in cancer
Montagut, A. M., Armengol, M., Gorjón-de-Pablo, G., Estrada‐Tejedor, R., Borrell, J. I., & Roué, G. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.02.007 · Cited by 17
Daxx and TCF4 interaction links to oral squamous cell carcinoma growth by promoting cell cycle progression via induction of cyclin D1 expression
Lin, G., Huang, Y., Lin, C., Huang, S., Shih, H., Sytwu, H., & Chen, Y. (2015) · Clinical Oral Investigations · doi:10.1007/s00784-015-1536-y · Cited by 17
Epigenetic modulation of PTEN expression during antiandrogenic therapies in human prostate cancer
Festuccia (2009) · International Journal of Oncology · doi:10.3892/ijo_00000429 · Cited by 17
Effects of PTEN gene alteration in patients with gallbladder cancer
Ali, A., Mishra, P. K., Sharma, S., Arora, A., & Saluja, S. S. (2015) · Cancer Genetics · doi:10.1016/j.cancergen.2015.09.007 · Cited by 16
High Expression of Ubiquitin C-terminalHydrolase L1 Is Associated With Poor Prognosis in Endometrial Cancer Patients
Nakao, K., Hirakawa, T., Suwa, H., Kogure, K., Ikeda, S., Yamashita, S., Minegishi, T., & Kishi, H. (2018) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000001201 · Cited by 16
HAUSP stabilizes Cdc25A and protects cervical cancer cells from DNA damage response
Das, S., Chandrasekaran, A. P., Jo, K.-S., Ko, N. R., Oh, S. J., Kim, K.-S., & Ramakrishna, S. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118835 · Cited by 16
USP7 promotes proliferation of papillary thyroid carcinoma cells through TBX3-mediated p57KIP2 repression
Xie, P., Wang, H., Xie, J., Huang, Z., Chen, S., Cheng, X., Zhang, X., Liu, F., Li, Y., & Huang, D. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.111037 · Cited by 16
Deubiquitylation and stabilization of ARMC5 by ubiquitin‐specific processing protease 7 (USP7) are critical for RCC proliferation
Yan, G., Liu, N., Tian, J., Fu, Y., Wei, W., Zou, J., Li, S., Wang, Q., Li, K., & Wang, J. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16306 · Cited by 16
Dysregulation of deubiquitination in breast cancer
Kong, L., & Jin, X. (2024) · Gene · doi:10.1016/j.gene.2024.148175 · Cited by 15
An Overview of Altered Pathways Associated with Sensitivity to Platinum-Based Chemotherapy in Neuroendocrine Tumors: Strengths and Prospects
Stefàno, E., Castro, F. D., Ciccarese, A., Muscella, A., Marsigliante, S., Benedetti, M., & Fanizzi, F. P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168568 · Cited by 15
Analysis of PTEN ubiquitylation and SUMOylation using molecular traps
Lang, V., Aillet, F., Silva-Ferrada, E. D., Xolalpa, W., Zabaleta, L., Rivas, C., & Rodríguez, M. S. (2014) · Methods · doi:10.1016/j.ymeth.2014.09.001 · Cited by 15
AMPK/TSC2/mTOR-signaling intermediates are not necessary for LKB1-mediated nuclear retention of PTEN tumor suppressor
Liu, J., Mao, Z., Gallick, G. E., & Yung, W. K. A. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq163 · Cited by 15
Small‐molecule inhibitors of ubiquitin‐specific protease 7 enhance type‐I interferon antiviral efficacy by destabilizing SOCS1
Yuan, Y., Miao, Y., Zeng, C.-H., Liu, J., Chen, X., Qian, L., Wang, X., Feng, Q., Yu, Z., Wang, J., et al. (2019) · Immunology · doi:10.1111/imm.13147 · Cited by 15
Clinical significance of USP7 and EZH2 in predicting prognosis of laryngeal squamous cell carcinoma and their possible functional mechanism.
Zhang, M.-J., Chen, D.-S., Li, H., Liu, W., Han, G., & Han, Y. (2019) · Europe PMC (PubMed Central) · Cited by 15
The Impact of the Ubiquitin System in the Pathogenesis of Squamous Cell Carcinomas
Gatti, V., Bernassola, F., Talora, C., Melino, G., & Peschiaroli, A. (2020) · Cancers · doi:10.3390/cancers12061595 · Cited by 15
Current Views on the Interplay between Tyrosine Kinases and Phosphatases in Chronic Myeloid Leukemia
Boni, C., & Sorio, C. (2021) · Cancers · doi:10.3390/cancers13102311 · Cited by 15
Prognostic role of USP7 expression in cancer patients: A systematic review and meta-analysis
Kisaï, K. K., & Koji, S. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153621 · Cited by 15
USP7 Inhibition Suppresses Neuroblastoma Growth via Induction of p53-Mediated Apoptosis and EZH2 and N-Myc Downregulation
Clorennec, C. L., Lee, K. S., Huo, Y., & Zage, P. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813780 · Cited by 16
Does Wnt/β-catenin pathway contribute to the stability of DNMT1 expression in urological cancer cell lines?
Varol, N., Konaç, E., & Bilen, C. Y. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214556951 · Cited by 14
Identification of Three Redundant Segments Responsible for Herpes Simplex Virus 1 ICP0 To Fuse with ND10 Nuclear Bodies
Zheng, Y., & Gu, H. (2015) · Journal of Virology · doi:10.1128/jvi.03658-14 · Cited by 14
HAUSP compartmentalization in chronic myeloid leukemia
Morotti, A., Panuzzo, C., Crivellaro, S., Carrà, G., Guerrasio, A., & Saglio, G. N. (2014) · European Journal Of Haematology · doi:10.1111/ejh.12422 · Cited by 14
The Adenovirus-Mediated Transfer ofPTENInhibits the Growth of Esophageal Cancer Cellsin Vitroandin Vivo
Zhou, Y., Zhang, T., Zhao, J., Wang, X., Jiang, T., Gu, Z., Wang, X., & Li, X. (2010) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.90787 · Cited by 14
The roles of KLHL family members in human cancers.
Ye, G., Wang, J., Yang, W., Li, J., Meng, Y., & Jin, X. (2022) · PubMed Central · Cited by 13
Ubiquitin-specific protease 7 inhibitors reveal a differentiated mechanism of p53-driven anti-cancer activity
Futran, A. S., Lu, T., Amberg-Johnson, K., Xu, J., Yang, X., He, S., Boyce, S., Bell, J., Pelletier, R. D., Suzuki, T., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109693 · Cited by 15
USP7 is associated with greater disease activity in systemic lupus erythematosus via stabilization of the IFNα receptor
Yu, Y., Su, Z., Wang, Z., & Hua-xi, X. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6819 · Cited by 13
HAUSP promoted the growth of glioma cells in vitro and in vivo via stabilizing NANOG
Cheng, C., Dong, Y., Niu, W., & Niu, C. (2020) · Pathology - Research and Practice · doi:10.1016/j.prp.2020.152883 · Cited by 13
Regulating the Master Regulator: Controlling Ubiquitination by Thinking Outside the Active Site
Paiva, S.-L., da Silva, S. R., de Araujo, E. D., & Gunning, P. T. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01346 · Cited by 13
Deubiquitinase USP48 promotes ATRA-induced granulocytic differentiation of acute promyelocytic leukemia cells
Li, L., Wang, Y., Zhang, X., Song, G., Guo, Q., Zhang, Z., Diao, Y., Yin, H., Liu, H., & Jiang, G. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4440 · Cited by 13
A High-Content Screening (HCS) Assay for the Identification of Chemical Inducers of PML Oncogenic Domains (PODs)
Yip, K. W., Cuddy, M., Pinilla, C., Giulanotti, M., Heynen‐Genel, S., Matsuzawa, S., & Reed, J. C. (2011) · SLAS DISCOVERY · doi:10.1177/1087057110394181 · Cited by 13
The Ubp15 deubiquitinase promotes timely entry into S phase inSaccharomyces cerevisiae
Ostapenko, D., Burton, J. L., & Solomon, M. J. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-09-1400 · Cited by 13
Integrative network analysis reveals USP7 haploinsufficiency inhibits E-protein activity in pediatric T-lineage acute lymphoblastic leukemia (T-ALL)
Shaw, T. I., Dong, L., Tian, L., Qian, C., Liu, Y., Ju, B., High, A. A., Kavdia, K., Pagala, V., Shaner, B., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-84647-2 · Cited by 13
Binding affinity and dissociation pathway predictions for a series of USP7 inhibitors with pyrimidinone scaffold by multiple computational methods
Wang, Z., Wang, X., Kang, Y., Zhong, H., Shen, C., Yao, X., Cao, D., & Hou, T. (2020) · Physical Chemistry Chemical Physics · doi:10.1039/d0cp00370k · Cited by 12
Cytoplasmic Protein Serine/Threonine Kinases
Thiriet, M. (2012) · Biomathematical and biomechanical modeling of the circulatory and ventilatory systems · doi:10.1007/978-1-4614-4370-4_5 · Cited by 11
RNA interference screens discover proteases as synthetic lethal partners of PI3K inhibition in breast cancer cells
Hölzen, L., Mitschke, J., Schönichen, C., Hess, M. E., Ehrenfeld, S., Boerries, M., Miething, C., Brummer, T., & Reinheckel, T. (2022) · Theranostics · doi:10.7150/thno.68299 · Cited by 11
Targeted therapy based on ubiquitin-specific proteases, signalling pathways and E3 ligases in non-small-cell lung cancer
Yang, Y., Zhao, C.-J., Jin, Z.-F., Zheng, J., & Ma, L. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1120828 · Cited by 11
Structure-Guided Discovery of Selective USP7 Inhibitors with In Vivo Activity
Vasas, A., Ivanschitz, L., Molnár, B., Kiss, Á., Baker, L. M., Fiumana, A., Macias, A. T., Murray, J. B., Sanders, E., Whitehead, N., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01472 · Cited by 11
The non-genomic loss of function of tumor suppressors: an essential role in the pathogenesis of chronic myeloid leukemia chronic phase
Crivellaro, S., Carrà, G., Panuzzo, C., Taulli, R., Guerrasio, A., Saglio, G. N., & Morotti, A. (2016) · BMC Cancer · doi:10.1186/s12885-016-2346-6 · Cited by 11
Novel insights into the impact of the SUMOylation pathway in hematological malignancies (Review)
Wang, L., Qian, J., Yang, Y., & Gu, C. (2021) · International Journal of Oncology · doi:10.3892/ijo.2021.5253 · Cited by 11
A Dialog on the First 20 Years of PML Research and the Next 20 Ahead
Bernardi, R., & Pandolfi, P. P. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00023 · Cited by 11
Self-citation
USP7 inhibition inhibits proliferation and induces megakaryocytic differentiation in MDS cells by upregulating gelsolin
Deng, J., Liang, L., Yi, H. J., Su, T., Yang, Z. ‐., Nie, L., & Liu, J. (2020) · British Journal of Haematology · doi:10.1111/bjh.16549 · Cited by 11
Tumor Suppressors in Chronic Lymphocytic Leukemia: From Lost Partners to Active Targets
Andreani, G., Carrà, G., Lingua, M. F., Maffeo, B., Brancaccio, M., Taulli, R., & Morotti, A. (2020) · Cancers · doi:10.3390/cancers12030629 · Cited by 11
Different Conformations of Phosphatase and Tensin Homolog, Deleted on Chromosome 10 (PTEN) Protein within the Nucleus and Cytoplasm of Neurons
Moncalero, V. L., Costanzo, R. V., Perandones, C., & Radrizzani, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018857 · Cited by 11
Ubiquitin-specific proteases (USPs) in leukemia: a systematic review
Zangooie, A., Tavoosi, S., Arabhosseini, M., Halimi, A., Zangooie, H., Baghsheikhi, A. H., Rahgozar, S., Ahmadvand, M., Jarrahi, A. M., & Salehi, Z. (2024) · BMC Cancer · doi:10.1186/s12885-024-12614-x · Cited by 10
Selective USP7 Inhibition Synergizes with MEK1/2 Inhibitor to Enhance Immune Responses and Potentiate Anti–PD-1 Therapy in NRAS-Mutant Melanoma
Su, L., Wang, D., Purwin, T. J., Ran, S., Yang, Q., Zhang, Q., & Cai, W. (2025) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2025.03.021 · Cited by 10
Expression of Ubiquitin-specific protease 7 in oral squamous cell carcinoma promotes tumor cell proliferation and invasion
Yang, X., Jin, J., Yang, J., Zhou, L., Mi, S., & Qi, G. (2021) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2021-0058 · Cited by 10
Discovery of a Potent and Selective Degrader for USP7
Pei, Y., Fu, J., Shi, Y., Zhang, M., Luo, G., Luo, X., Song, N., Mi, T., Yang, Y., Li, J. X., et al. (2022) · Angewandte Chemie · doi:10.1002/ange.202204395 · Cited by 10
The role of ubiquitin pathway‐mediated regulation of immune checkpoints in cancer immunotherapy
Zhou, X., Fu, C., & Chen, X. (2023) · Cancer · doi:10.1002/cncr.34729 · Cited by 10
USP7 reduces the level of nuclear DICER , impairing DNA damage response and promoting cancer progression
Liu, X., Lu, R., Yang, Q., He, J., Huang, C., Cao, Y., Zhou, Z., Huang, J., Li, L., Chen, R., et al. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13543 · Cited by 10
Future Cancer Therapy with Molecularly Targeted Therapeutics: Challenges and Strategies
Kim, M.-S. (2011) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2011.19.4.371 · Cited by 10
In Cell and In Vitro Assays to Measure PTEN Ubiquitination
Gupta, A. K., Maccario, H., Kriplani, N., & Leslie, N. R. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3299-3_11 · Cited by 10
The deubiquitinating enzyme USP7 regulates the transcription factor Nrf1 by modulating its stability in response to toxic metal exposure
Han, J. J. W., Ho, D. V., Kim, H. M., Lee, J. Y., Jeon, Y. S., & Chan, J. Y. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100732 · Cited by 12
A Single Amino Acid Switch in the Adenoviral DNA Binding Protein Abrogates Replication Center Formation and Productive Viral Infection
Boddin, J., Ip, W.-H., Wilkens, B., von Stromberg, K., Ching, W., Koyuncu, E., Bertzbach, L. D., & Dobner, T. (2022) · mBio · doi:10.1128/mbio.00144-22 · Cited by 10
Smurf1 Suppression Enhances Temozolomide Chemosensitivity in Glioblastoma by Facilitating PTEN Nuclear Translocation
Dong, L., Li, Y., Liu, L., Meng, X., Li, S., Han, D., Xiao, Z., & Xia, Q. (2022) · Cells · doi:10.3390/cells11203302 · Cited by 10
Signaling Lipids
Thiriet, M. (2012) · Biomathematical and biomechanical modeling of the circulatory and ventilatory systems · doi:10.1007/978-1-4614-4370-4_2 · Cited by 9
Discovery of a Highly Potent, Selective and Efficacious USP7 Degrader for the Treatment of Acute Lymphoblastic Leukemia
Xu, M., Fu, J., Pei, Y., Li, M., Kan, W., Yan, R., Xia, C., Ma, J., Wang, P., Zhang, Y., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01134 · Cited by 9
Ubiquitin‐specific protease 7 mediates platelet‐derived growth factor‐induced pulmonary arterial smooth muscle cells proliferation
Zhu, Y., Zhang, Q., Yan, X., Liu, L., Zhai, C., Wang, Q., Chai, L., & Li, M. (2021) · Pulmonary Circulation · doi:10.1177/20458940211046131 · Cited by 9
The E3 ubiquitin ligase CHIP drives monoubiquitylation-mediated nuclear import of the tumor suppressor PTEN
Chakraborty, S., Karmakar, S., Basu, M., Kal, S., & Ghosh, M. K. (2023) · Journal of Cell Science · doi:10.1242/jcs.260950 · Cited by 9
Relevance of poly (ADP-ribose) polymerase inhibitors in prostate cancer
Rescigno, P., Chandler, R. W., & Bono, J. S. D. (2018) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000358 · Cited by 9
MiR-15b regulates cell differentiation and survival by targeting CCNE1 in APL cell lines
Yuan, Z., Zhong, L., Liu, D., Yao, J., Liu, J., Zhong, P., Yao, S., Zhao, Y., Li, L., Chen, M., et al. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.04.005 · Cited by 9

Authors: Song, M. S., Salmena, L., Carracedo, A., Egia, A., Lo-Coco, F., Teruya-Feldstein, J., & Pandolfi, P. P.
Affiliations: Beth Israel Deaconess Medical Center (US)
Corresponding author: Pandolfi, Pier Paolo
ORCID: Salmena, Leonardo
Carracedo, Arkaitz
Pandolfi, Pier Paolo
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2008-08-20
Volume: 455
Issue: 7214
Pages: 813-817
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature07290
PMC: PMC3398484
OpenAlex: W2162648910
Cited by: 548
References: 34
Citations by year: 2026: 15 · 2025: 27 · 2024: 22 · 2023: 35 · 2022: 25 · 2021: 37 · 2020: 43 · 2019: 40 · 2018: 33 · 2017: 39 · 2016: 34 · 2015: 36 · 2014: 32 · 2013: 27 · 2012: 31
FWCI: 9.86
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
Funders: European Molecular Biology Organization
National Institutes of Health
National Cancer Institute (R01CA082328, P50CA092629)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords: PTEN, USP7, PML, nuclear localization, PML nuclear bodies, DAXX, PML-RARA fusion, acute promyelocytic leukemia, all-trans retinoic acid, arsenic trioxide, prostate cancer, tumor suppressor regulation, ubiquitination, nuclear-cytoplasmic trafficking
MeSH terms: Promyelocytic Leukemia Protein, Ubiquitin-Specific Peptidase 7, Animals, Cell Nucleus, Fibroblasts, Humans, Male, Nuclear Proteins, Prostatic Neoplasms, Transcription Factors, Tretinoin, Ubiquitins, Leukemia, Promyelocytic, Acute, Apoptosis, Molecular Chaperones, Active Transport, Cell Nucleus, Tumor Suppressor Proteins, Ubiquitin Thiolesterase, Cell Line, Tumor, Adaptor Proteins, Signal Transducing, PTEN Phosphohydrolase, Mice, Ubiquitination, Co-Repressor Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks